Par Drugs and Chemicals Limited (NSEI: PAR)
Health Care · Pharmaceuticals · IN
Rs117.10
-5.53% today · +14.6% 1Y
Par Drugs and Chemicals Limited (NSEI: PAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.89M and employs 118 people.
Over the last twelve months the share price has gained 14.6%, trading between 78.05 and 180.00.
Tweenvest scores Par Drugs and Chemicals Limited across four factors: quality 82/100, value 72/100, growth 13/100. Its strongest factor is quality.
PAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.89M
- Revenue (TTM)
- $11.52M
- P/E
- 9.94
- EPS
- 11.78
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- Rs180.00
- 52-week low
- Rs78.05
- Avg volume (3M)
- —
- Shares outstanding
- 12.30M
- Employees
- 118
- Next earnings
- —
About Par Drugs and Chemicals Limited
Par Drugs and Chemicals Limited is an Indian enterprise that focuses on the creation, production, and sale of active pharmaceutical ingredients (APIs) and specialized chemicals. Its comprehensive product line features a diverse array of compounds, such as magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, as well as various amorphous and custom-blended formulations. The company also extends its market presence through international exports. Founded in 1982, Par Drugs and Chemicals Limited is headquartered in Vadodara, India.
- ISIN
- INE04LG01015
- Founded
- 1982
- Listed since
- May 30, 2019
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
Figures last refreshed Oct 11, 2026.